FDA Approved: VIGABATRIN — Supplemental Application (Edenbridge Pharmaceuticals LLC.)

View source ↗

Summary

FDA approved a supplemental application for Vigabatrin from Edenbridge Pharmaceuticals LLC. under ANDA 215109.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Partial Seizures
• Epilepsy
• Infantile Spasms

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)